Inotiv Inc
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences researc… Read more
Market Cap & Net Worth: Inotiv Inc (NOTV)
Inotiv Inc (NASDAQ:NOTV) has a market capitalization of $12.43 Million ($12.43 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27908 globally and #9335 in its home market, demonstrating a -2.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inotiv Inc's stock price $0.36 by its total outstanding shares 34396621 (34.40 Million).
Inotiv Inc Market Cap History: 2015 to 2026
Inotiv Inc's market capitalization history from 2015 to 2026. Data shows change from $52.28 Million to $12.43 Million (-13.32% CAGR).
Index Memberships
Inotiv Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #733 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.00% | #2346 of 3165 |
Weight: Inotiv Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Inotiv Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inotiv Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Inotiv Inc's market cap is 0.04 times its annual revenue
0.68x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $26.49 Million | $20.44 Million | -$3.23 Million | 1.30x | N/A |
| 2017 | $84.27 Million | $24.24 Million | $884.00K | 3.48x | 95.33x |
| 2018 | $43.68 Million | $26.35 Million | -$194.00K | 1.66x | N/A |
| 2019 | $170.26 Million | $43.62 Million | -$790.00K | 3.90x | N/A |
| 2020 | $423.08 Million | $60.47 Million | -$4.68 Million | 7.00x | N/A |
| 2021 | $1.45 Billion | $89.61 Million | $10.89 Million | 16.15x | 132.82x |
| 2022 | $169.92 Million | $547.66 Million | -$337.26 Million | 0.31x | N/A |
| 2023 | $126.24 Million | $572.42 Million | -$105.14 Million | 0.22x | N/A |
| 2024 | $142.40 Million | $490.74 Million | -$108.44 Million | 0.29x | N/A |
| 2025 | $19.33 Million | $513.02 Million | -$68.62 Million | 0.04x | N/A |
Competitor Companies of NOTV by Market Capitalization
Companies near Inotiv Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Inotiv Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Inotiv Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Inotiv Inc's market cap moved from $52.28 Million to $ 12.43 Million, with a yearly change of -13.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $12.43 Million | -35.72% |
| 2025 | $19.33 Million | -86.42% |
| 2024 | $142.40 Million | +12.81% |
| 2023 | $126.24 Million | -25.71% |
| 2022 | $169.92 Million | -88.26% |
| 2021 | $1.45 Billion | +242.03% |
| 2020 | $423.08 Million | +148.48% |
| 2019 | $170.26 Million | +289.76% |
| 2018 | $43.68 Million | -48.16% |
| 2017 | $84.27 Million | +218.18% |
| 2016 | $26.49 Million | -49.34% |
| 2015 | $52.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Inotiv Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.43 Million USD |
| MoneyControl | $12.43 Million USD |
| MarketWatch | $12.43 Million USD |
| marketcap.company | $12.43 Million USD |
| Reuters | $12.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.